de Dimensional Fund Advisors ANI Pharmaceuticals ANIP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 51.6 M | Comprar |
623,463
+92,273
| +17% | +USD 7.4 M | 0.01% | 1586 |
|
|
2026
Q1 | USD 40.8 M | Comprar |
531,190
+43,523
| +9% | +USD 3.4 M | 0.01% | 1608 |
|
|
2025
Q4 | USD 38.5 M | Vender |
487,667
-17,761
| -4% | -USD 1.54 M | 0.01% | 1648 |
|
|
2025
Q3 | USD 46.3 M | Vender |
505,428
-48,465
| -9% | -USD 3.95 M | 0.01% | 1563 |
|
|
2025
Q2 | USD 36.1 M | Vender |
553,893
-77,668
| -12% | -USD 5.06 M | 0.01% | 1676 |
|
|
2025
Q1 | USD 42.3 M | Vender |
631,561
-54,169
| -8% | -USD 3.24 M | 0.01% | 1557 |
|
|
2024
Q4 | USD 37.9 M | Comprar |
685,730
+30,420
| +5% | +USD 1.75 M | 0.01% | 1681 |
|
|
2024
Q3 | USD 39.1 M | Comprar |
655,310
+25,084
| +4% | +USD 1.53 M | 0.01% | 1651 |
|
|
2024
Q2 | USD 40.1 M | Comprar |
630,226
+21,053
| +3% | +USD 1.37 M | 0.01% | 1597 |
|
|
2024
Q1 | USD 42.1 M | Comprar |
609,173
+17,442
| +3% | +USD 1.05 M | 0.01% | 1581 |
|
|
2023
Q4 | USD 32.6 M | Comprar |
591,731
+33,359
| +6% | +USD 1.84 M | 0.01% | 1719 |
|
|
2023
Q3 | USD 32.4 M | Comprar |
558,372
+14,430
| +3% | +USD 833 k | 0.01% | 1632 |
|
|
2023
Q2 | USD 29.3 M | Comprar |
543,942
+12,750
| +2% | +USD 565 k | 0.01% | 1719 |
|
|
2023
Q1 | USD 21.1 M | Comprar |
+531,192
| Nuevas | +USD 22.4 M | 0.01% | 1880 |
|
|
2022
Q3 | USD 16.9 M | Vender |
525,449
-13,294
| -2% | -USD 455 k | 0.01% | 1915 |
|
|
2022
Q2 | USD 16 M | Comprar |
538,743
+82,596
| +18% | +USD 2.38 M | 0.01% | 1985 |
|
|
2022
Q1 | USD 12.8 M | Comprar |
456,147
+66,843
| +17% | +USD 2.49 M | ﹤0.01% | 2185 |
|
|
2021
Q4 | USD 17.9 M | Comprar |
389,304
+11,088
| +3% | +USD 476 k | 0.01% | 2044 |
|
|
2021
Q3 | USD 12.4 M | Vender |
378,216
-60,960
| -14% | -USD 1.9 M | ﹤0.01% | 2229 |
|
|
2021
Q2 | USD 15.4 M | Comprar |
439,176
+30,862
| +8% | +USD 1.05 M | ﹤0.01% | 2173 |
|
|
2021
Q1 | USD 14.7 M | Vender |
408,314
-19,340
| -5% | -USD 606 k | ﹤0.01% | 2154 |
|
|
2020
Q4 | USD 12.4 M | Vender |
427,654
-15,118
| -3% | -USD 433 k | ﹤0.01% | 2195 |
|
|
2020
Q3 | USD 12.5 M | Vender |
442,772
-52,891
| -11% | -USD 1.57 M | 0.01% | 2090 |
|
|
2020
Q2 | USD 16 M | Vender |
495,663
-6,496
| -1% | -USD 233 k | 0.01% | 1974 |
|
|
2020
Q1 | USD 20.5 M | Vender |
502,159
-18,712
| -4% | -USD 995 k | 0.01% | 1730 |
|
|
2019
Q4 | USD 32.1 M | Vender |
520,871
-15,069
| -3% | -USD 998 k | 0.01% | 1773 |
|
|
2019
Q3 | USD 39.1 M | Vender |
535,940
-1,487
| -0.3% | -USD 111 k | 0.02% | 1598 |
|
|
2019
Q2 | USD 44.2 M | Comprar |
537,427
+2,434
| +0.5% | +USD 173 k | 0.02% | 1543 |
|
|
2019
Q1 | USD 37.7 M | Comprar |
534,993
+16,566
| +3% | +USD 975 k | 0.02% | 1655 |
|
|
2018
Q4 | USD 23.3 M | Comprar |
518,427
+6,546
| +1% | +USD 343 k | 0.01% | 1903 |
|
|
2018
Q3 | USD 28.9 M | Comprar |
511,881
+32,556
| +7% | +USD 1.99 M | 0.01% | 1904 |
|
|
2018
Q2 | USD 32 M | Comprar |
479,325
+11,081
| +2% | +USD 692 k | 0.01% | 1826 |
|
|
2018
Q1 | USD 27.3 M | Comprar |
468,244
+12,427
| +3% | +USD 789 k | 0.01% | 1875 |
|
|
2017
Q4 | USD 29.4 M | Comprar |
455,817
+31,020
| +7% | +USD 1.93 M | 0.01% | 1843 |
|
|
2017
Q3 | USD 22.3 M | Comprar |
424,797
+85,529
| +25% | +USD 4.08 M | 0.01% | 1988 |
|
|
2017
Q2 | USD 15.9 M | Comprar |
339,268
+161,743
| +91% | +USD 7.8 M | 0.01% | 2149 |
|
|
2017
Q1 | USD 8.79 M | Comprar |
177,525
+86,011
| +94% | +USD 4.83 M | ﹤0.01% | 2369 |
|
|
2016
Q4 | USD 5.55 M | Comprar |
91,514
+43,534
| +91% | +USD 2.66 M | ﹤0.01% | 2515 |
|
|
2016
Q3 | USD 3.18 M | Comprar |
47,980
+33,654
| +235% | +USD 2.1 M | ﹤0.01% | 2656 |
|
|
2016
Q2 | USD 800 k | Comprar |
14,326
+403
| +3% | +USD 19.6 k | ﹤0.01% | 2970 |
|
|
2016
Q1 | USD 469 k | Mantener |
13,923
| – | – | ﹤0.01% | 3057 |
|
|
2015
Q4 | USD 628 k | Mantener |
13,923
| – | – | ﹤0.01% | 3046 |
|
|
2015
Q3 | USD 550 k | Mantener |
13,923
| – | – | ﹤0.01% | 3105 |
|
|
2015
Q2 | USD 864 k | Comprar |
13,923
+8,440
| +154% | +USD 502 k | ﹤0.01% | 3048 |
|
|
2015
Q1 | USD 343 k | Mantener |
5,483
| – | – | ﹤0.01% | 3161 |
|
|
2014
Q4 | USD 309 k | Vender |
5,483
-4,047
| -42% | -USD 178 k | ﹤0.01% | 3200 |
|
|
2014
Q3 | USD 270 k | Mantener |
9,530
| – | – | ﹤0.01% | 3234 |
|
|
2014
Q2 | USD 328 k | Vender |
9,530
-175
| -2% | -USD 5.49 k | ﹤0.01% | 3251 |
|
|
2014
Q1 | USD 304 k | Mantener |
9,705
| – | – | ﹤0.01% | 3256 |
|
|
2013
Q4 | USD 195 k | Mantener |
9,705
| – | – | ﹤0.01% | 3296 |
|
|
2013
Q3 | USD 95 k | Comprar |
9,705
+1,165
| +14% | +USD 8.4 k | ﹤0.01% | 3394 |
|
|
2013
Q2 | USD 51 k | Comprar |
+8,540
| Nuevas | +USD 59.8 k | ﹤0.01% | 3439 |
|
Otros fondos que tienen ANIP en su cartera
Posición de Dimensional Fund Advisors en ANIP: resumen de T2 2026
Dimensional Fund Advisors aumentó su participación en ANI Pharmaceuticals (ANIP) en 17% durante T2 2026, al comprar aproximadamente USD 7.4 M y elevar la posición a 623,463 acciones con un valor de USD 51.6 M. La posición representa 0.01% de la cartera y ocupa el puesto #1586.
Dimensional Fund Advisors reportó por primera vez una posición en ANIP en T2 2013 y la ha mantenido durante 52 trimestres desde entonces. Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank mantienen una posición en ANIP.
- Al cierre de T2 2026, Dimensional Fund Advisors tenía 623,463 acciones de ANI Pharmaceuticals con un valor de USD 51.6 M.
- Dimensional Fund Advisors compró 92,273 acciones de ANI Pharmaceuticals en T2 2026, por un monto estimado de USD 7.4 M.
- ANI Pharmaceuticals representó 0.01% de la cartera de Dimensional Fund Advisors en T2 2026 y fue su posición número 1586.
- Dimensional Fund Advisors reportó por primera vez una posición en ANI Pharmaceuticals en T2 2013 y la ha mantenido durante 52 trimestres desde entonces.
- Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank tenían ANI Pharmaceuticals en cartera.
Según el Informe 13F de Dimensional Fund Advisors correspondiente a T2 2026, presentado el 11 ago 2026.